3Reiter R E,Gu Z,Watabe T,etal.Prostate stem cell antigen:a cell surface marker overexpressed in prostate cancer.Proc Natl Acad Sci USA,1998,95:1735-1740.
4Reiter R E,Sato I,Thomas G,etal.Coamplification of prostate stem cell antigen (PSCA) and MYC in locally advanced prostate cancer.Genes Chromosomes Cancer,2000,27:95-103.
5Bahrenberg G,Brauers A,Joost H G,etal.PSCA expression is regulated by phorbol ester and cell adhesion in the bladder carcinoma cell line RT112.Cancer Lett,2001,168:37-43.
6Bahrenberg G,Brauers A,Joost H G,etal.Reduced expression of PSCA,a member of the LY-6 family of cell surface antigens,in bladder,esophagus,and stomach tumors.Biochem Biophys Res Commun,2000,275:783-788.
7Mikolajczyk SD, Catalona WJ, Evans CL, et al. Proenzyme forms of prostate-specific antigen in serum improve the detection of prostate cancer[J]. Clin Chem,2004,50(6) :1017-1025.
8aStamey TA. Preoperation serum prostate-specific antigen (PSA) below 10 μg/L predicats neither the presence of prostate cancer nor the rate of postoperation PSA failure[ J]. Clin Chem ,2001,47 (4) :631-634.
9Thompson IM, Pauler DK, Goodman PJ, et al. Prevalence of prosrate cancer among men with a prostate-specific antigen level ≤4 μg/L[ J]. N Engl ned,2004,350(22) :2239-2246.
10Reeker F, Kwiatkowski MK, Pironen T, et al. Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostatespecific antigen [ J ]. Urology, 2000,55 ( 3 ) :481-485.
